PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.
3.81%
ROE of 3.81% versus zero median in Medical - Pharmaceuticals. Walter Schloss would verify if slight profitability advantage matters long-term.
1.19%
ROA of 1.19% while Medical - Pharmaceuticals median is zero. Peter Lynch would see if minimal profitability can widen over time.
4.24%
ROCE of 4.24% while Medical - Pharmaceuticals median is zero. Walter Schloss would see if moderate profitability can widen vs. peers.
20.77%
Gross margin below 50% of Medical - Pharmaceuticals median of 54.94%. Jim Chanos would suspect flawed products or pricing.
2.57%
Margin of 2.57% while Medical - Pharmaceuticals median is zero. Walter Schloss would see if moderate profitability can be leveraged further.
1.66%
Net margin of 1.66% while Medical - Pharmaceuticals is zero. Walter Schloss would examine if modest profitability can expand.